AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$13.34
−$0.32 (−2.38%) 4:00 PM ET
After hours$13.18
−$0.16 (−1.20%) 7:02 PM ET
Prev closePrevC$13.66
OpenOpen$13.73
Day highHigh$13.73
Day lowLow$13.03
VolumeVol2,306,041
Avg volAvgVol3,098,497
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$1.71B
P/E ratio
-0.67
FY Revenue
$3.43B
EPS
-20.01
Gross Margin
35.31%
Sector
Materials
AI report sections
MIXED
FMC
FMC Corporation
FMC’s share price has staged a short-term rebound with 1–3 month gains and bullish technical momentum after a deep drawdown that leaves it near the lower end of its 52-week range. At the same time, fundamentals show steep losses, negative free cash flow, and highly negative returns on equity and assets, indicating substantial underlying business pressure. Valuation multiples on sales and book value appear modest, but the very high dividend yield and elevated leverage suggest the current capital structure and payout may be under strain.
AI summarized at 12:22 AM ET, 2026-04-01
AI summary scores
INTRADAY:68SWING:63LONG:22
Volume vs average
Intraday (cumulative)
−4% (Below avg)
Vol/Avg: 0.96×
RSI
46.60(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.02 Signal: -0.01
Short-Term
+0.11 (Strong)
MACD: -0.50 Signal: -0.61
Long-Term
-0.02 (Weak)
MACD: -0.69 Signal: -0.67
Intraday trend score
40.19
LOW30.19HIGH47.19
Latest news
FMC•12 articles•Positive: 4Neutral: 3Negative: 5
NegativeThe Motley Fool• Billy Duberstein
FMC Corp. Just Agreed to Sell Its India Commercial Business. Here's What That Means for the Stock in 2026.
FMC Corp. announced the sale of its India commercial business to Crystal Crop Protection Limited for $252 million to reduce debt and exit a problematic market. While a positive step, the sale will only reduce FMC's $4.5 billion debt load by 5.6%. The company faces significant headwinds including expired patents, weak agricultural markets, and declining revenue and EBITDA, with its turnaround dependent on new product development and potential acquisition.
While the India business sale is presented as a positive step, the article emphasizes that it addresses only a small portion of FMC's problems. The company faces significant challenges including expired patents, weak agricultural markets, declining revenue and EBITDA, a 92% dividend cut, and substantial debt. The author concludes FMC's survival remains uncertain and dependent on multiple unresolved factors.
NegativeThe Motley Fool• Eric Volkman
Why FMC Stock Was Sinking This Week
FMC stock fell 9% this week after announcing a $1.2 billion debt issuance of senior secured notes at 8% interest to refinance existing unsecured notes maturing in October at 3.2%. The higher borrowing costs and increased debt burden concerned investors, as the company will pay significantly more in interest expenses while adding to its overall debt load.
The company is taking on debt at 8% interest to refinance lower-cost debt at 3.2%, resulting in significantly higher interest expenses and increased debt burden. This unfavorable refinancing and deteriorating financial position led to a 9% stock decline. The analyst explicitly states they would be 'leery' about investing in FMC stock.
NegativeThe Motley Fool• Jonathan Ponciano
Why This $4.4 Million Exit Looks Bearish for a Chemicals Stock Down 50%
Old North State Wealth Management completely exited its FMC Corporation position by selling 295,829 shares worth approximately $4.42 million in Q1 2026. The exit signals diminishing confidence in the company's recovery prospects, as FMC faces significant challenges including an 18% revenue decline, a $2.24 billion net loss, and further projected revenue declines for 2026. The stock has fallen 50% over the past year while underperforming the S&P 500.
Complete liquidation of a major holder's position signals loss of confidence. The company is experiencing severe financial distress with an 18% revenue decline, $2.24 billion net loss, projected further revenue declines, and is considering strategic alternatives including a potential sale. Stock has underperformed significantly, down 50% year-over-year versus S&P 500's 35% gain.
PositiveThe Motley Fool• Billy Duberstein
Why FMC Rallied in March, Even As Markets Fell
FMC Corporation rallied 16.8% in March despite a challenging 2025 due to two main factors: the Iran war creating a supply crunch in agricultural chemicals, and CEO announcements that 5-10 parties are interested in acquiring the company. However, the stock remains risky given high debt levels, industry cyclicality, and uncertain earnings impact from the supply crunch.
Stock rallied 16.8% in March driven by supply chain tightening from Iran conflict and multiple acquisition interest from 5-10 parties. New herbicide (Isoflex) EU approval provides additional upside potential.
NeutralThe Motley Fool• Lawrence Rothman, Cfa
Is an FMC Takeover on the Horizon? Here's What Investors Need to Know.
FMC Corporation announced in February it would pursue strategic options including a potential sale to unlock shareholder value. While the company has attracted interest from corporate and private equity buyers who believe in its product pipeline, recent financial results have been underwhelming with 2025 revenue down 5% and EPS down 14.9% year-over-year. The stock has surged 28% since the announcement, but analysts caution that much of the upside may already be priced in, and investors should be wary of betting on an uncertain acquisition outcome.
FMCFMC takeoverstrategic alternativesacquisitionrevenue declineproduct pipelineprivate equityshareholder value
Sentiment note
While FMC has attracted takeover interest and the stock has rallied 28% since the announcement, the company faces headwinds with declining revenue (-5%) and earnings (-14.9% EPS). The article suggests the acquisition is uncertain and much of the upside may already be priced in. The neutral sentiment reflects both the potential upside from a takeover and the significant downside risk if a deal doesn't materialize.
U.S. equity markets rebounded from seven-month lows on Monday as President Trump disclosed negotiations with Iran and Fed Chair Powell downplayed imminent rate hikes, calling tariffs a 'one-time price bump.' Treasury yields fell significantly, boosting financial, materials, and real estate sectors. Major indices gained broadly, with the S&P 500 up 0.7%, Dow up 1.1%, and Nasdaq 100 up 0.5%.
Advanced 6.73%, benefiting from materials sector strength
PositiveThe Motley Fool• Billy Duberstein
Why FMC Corporation Rallied 20% This Week
FMC Corporation surged 19.6% this week as Middle East conflict disruptions boost fertilizer prices globally. A Citigroup analyst raised the price target from $14 to $15, citing supply constraints. Additionally, the company's CEO disclosed exploration of potential buyout offers from 5-10 interested parties. However, analysts caution that FMC remains a risky turnaround play given its 72% decline in 2025 and substantial debt load.
FMCCCPNCPRFMC Corporationfertilizer pricesMiddle East conflictsupply disruption
Sentiment note
Stock rallied 19.6% this week driven by improved fertilizer pricing outlook from supply disruptions and potential buyout interest from multiple parties. However, sentiment is tempered by acknowledgment of substantial risks including prior 72% decline in 2025, high debt load, and reliance on uncertain geopolitical factors.
NegativeThe Motley Fool• Lawrence Rothman, Cfa
Is FMC Stock Going to $15?
FMC Corporation's stock would need a 15% gain to reach $15, but the article suggests this is unlikely. The crop protection company faces significant headwinds with adjusted revenue declining 5% last year and management expecting another 5% decline this year. While the company is exploring strategic options including a potential sale, the weak fundamentals and lack of profitability make reaching the $15 target a difficult prospect without a major turnaround or acquisition.
The company faces significant operational challenges including a 5% revenue decline last year with another 5% decline expected, a GAAP loss of $2.2 billion, a 68.5% stock price drop over the past year, and weak management guidance. While exploring a potential sale, the fundamentals suggest reaching the $15 price target is unlikely without major improvements or an acquisition at a premium valuation.
NeutralThe Motley Fool• Thomas Niel
Where Will FMC Stock Be in 1 Year?
FMC stock has fallen two-thirds over the past year due to industry headwinds and patent expirations in the agricultural chemicals sector. Despite challenges including declining revenue and earnings, the stock may present a buying opportunity for new investors due to two potential catalysts: a possible strategic acquisition at a premium price and new patented crop protection products. Trading at 8-9x forward earnings compared to competitors' mid-teens multiples, FMC appears undervalued, though the investment remains highly speculative.
While the company faces significant headwinds (67% stock decline, revenue/earnings drops, patent expirations, dividend cut), the article presents a balanced view highlighting undervaluation and two potential catalysts (strategic acquisition or new product success) that could drive recovery. The author acknowledges high speculation but sees favorable risk/reward at current prices.
PositiveBenzinga• Prnewswire
FMC Corporation Declares Quarterly Dividend
FMC Corporation announced a regular quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of March 31, 2026. The agricultural sciences company continues its dividend distribution program.
The declaration of a regular quarterly dividend demonstrates the company's financial stability and commitment to returning capital to shareholders. Consistent dividend payments are typically viewed positively by investors as they indicate confidence in the company's cash flow and business performance.
NeutralThe Motley Fool• Rick Munarriz
2 Top Bargain Stocks Ready for a Bull Run
FMC Corporation and Camping World are presented as potential bargain stocks despite significant challenges. Both companies have slashed dividends dramatically (FMC by 86%, Camping World suspended entirely) and experienced sharp stock price declines over the past year. FMC faces declining revenue and earnings in the agricultural sector with patent expirations, while Camping World struggles with inventory management in a cyclical RV market. However, the author argues both stocks are undervalued and could recover, with FMC trading at 8.5x forward earnings and exploring strategic alternatives.
Mixed outlook with significant near-term challenges (declining revenue/earnings, 86% dividend cut, $4B debt) but potentially attractive valuation at 8.5x forward earnings. Company exploring strategic alternatives could provide upside, but business stabilization is uncertain.
NegativeThe Motley Fool• Rich Smith
Is FMC Stock a Buy Now or a Falling Knife?
FMC Corporation has faced significant challenges with back-to-back poor earnings quarters and a 50% stock price decline. While the stock has stabilized around $14.50, the company reported an 18% revenue decline in 2025 and massive losses. FMC is exploring strategic options including a potential sale and plans to strengthen its balance sheet through asset sales and new product launches. However, the analyst recommends against investing unless the company is acquired, citing expensive valuation metrics and a lengthy turnaround timeline.
The company reported consecutive poor earnings quarters with 49% sales drop in Q3, 18% full-year revenue decline in 2025, and massive per-share losses ($17.88). While management has a turnaround plan including asset sales and new herbicide launches, the analyst explicitly recommends against investing unless acquired. The company faces a lengthy recovery timeline with forecasted 5% revenue decline in 2026 and expensive 30x FCF valuation relative to debt load.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal